Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during March 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Panacea Biotec submitted a routine regulatory compliance filing confirming that no shares were dematerialized during March 2026. The company provided cumulative dematerialization figures as of March 31, 2026: NSDL held 5,35,51,635 shares and CDSL held 75,52,891 shares, totaling 6,11,04,526 dematerialized shares. This filing is mandatory under SEBI regulations requiring issuers to report securities dematerialization to stock exchanges. The RTA certificate was obtained from Skyline Financial Services Pvt. Ltd.
This is a routine compliance filing with no impact on shareholders or stock price. It simply confirms the status of dematerialized shares and does not indicate any new corporate action or material change.